Cargando…
Excellent response to β-1 adrenergic receptor blockade (metoprolol) and exercise restriction in high-risk type 1 long QT syndrome. A 22-year follow-up
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039562/ https://www.ncbi.nlm.nih.gov/pubmed/35492848 http://dx.doi.org/10.1016/j.hrcr.2021.12.006 |
| _version_ | 1784694156365398016 |
|---|---|
| author | Tejeda-Mollinedo, Williams Díaz-Tostado, Sergio Gómez-Flores, Jorge Nava-Townsend, Santiago Levinstein-Jacinto, Moises Márquez, Manlio F. |
| author_facet | Tejeda-Mollinedo, Williams Díaz-Tostado, Sergio Gómez-Flores, Jorge Nava-Townsend, Santiago Levinstein-Jacinto, Moises Márquez, Manlio F. |
| author_sort | Tejeda-Mollinedo, Williams |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9039562 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90395622022-04-27 Excellent response to β-1 adrenergic receptor blockade (metoprolol) and exercise restriction in high-risk type 1 long QT syndrome. A 22-year follow-up Tejeda-Mollinedo, Williams Díaz-Tostado, Sergio Gómez-Flores, Jorge Nava-Townsend, Santiago Levinstein-Jacinto, Moises Márquez, Manlio F. HeartRhythm Case Rep Case Report Elsevier 2021-12-11 /pmc/articles/PMC9039562/ /pubmed/35492848 http://dx.doi.org/10.1016/j.hrcr.2021.12.006 Text en © 2021 Heart Rhythm Society. Published by Elsevier Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Case Report Tejeda-Mollinedo, Williams Díaz-Tostado, Sergio Gómez-Flores, Jorge Nava-Townsend, Santiago Levinstein-Jacinto, Moises Márquez, Manlio F. Excellent response to β-1 adrenergic receptor blockade (metoprolol) and exercise restriction in high-risk type 1 long QT syndrome. A 22-year follow-up |
| title | Excellent response to β-1 adrenergic receptor blockade (metoprolol) and exercise restriction in high-risk type 1 long QT syndrome. A 22-year follow-up |
| title_full | Excellent response to β-1 adrenergic receptor blockade (metoprolol) and exercise restriction in high-risk type 1 long QT syndrome. A 22-year follow-up |
| title_fullStr | Excellent response to β-1 adrenergic receptor blockade (metoprolol) and exercise restriction in high-risk type 1 long QT syndrome. A 22-year follow-up |
| title_full_unstemmed | Excellent response to β-1 adrenergic receptor blockade (metoprolol) and exercise restriction in high-risk type 1 long QT syndrome. A 22-year follow-up |
| title_short | Excellent response to β-1 adrenergic receptor blockade (metoprolol) and exercise restriction in high-risk type 1 long QT syndrome. A 22-year follow-up |
| title_sort | excellent response to β-1 adrenergic receptor blockade (metoprolol) and exercise restriction in high-risk type 1 long qt syndrome. a 22-year follow-up |
| topic | Case Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039562/ https://www.ncbi.nlm.nih.gov/pubmed/35492848 http://dx.doi.org/10.1016/j.hrcr.2021.12.006 |
| work_keys_str_mv | AT tejedamollinedowilliams excellentresponsetob1adrenergicreceptorblockademetoprololandexerciserestrictioninhighrisktype1longqtsyndromea22yearfollowup AT diaztostadosergio excellentresponsetob1adrenergicreceptorblockademetoprololandexerciserestrictioninhighrisktype1longqtsyndromea22yearfollowup AT gomezfloresjorge excellentresponsetob1adrenergicreceptorblockademetoprololandexerciserestrictioninhighrisktype1longqtsyndromea22yearfollowup AT navatownsendsantiago excellentresponsetob1adrenergicreceptorblockademetoprololandexerciserestrictioninhighrisktype1longqtsyndromea22yearfollowup AT levinsteinjacintomoises excellentresponsetob1adrenergicreceptorblockademetoprololandexerciserestrictioninhighrisktype1longqtsyndromea22yearfollowup AT marquezmanliof excellentresponsetob1adrenergicreceptorblockademetoprololandexerciserestrictioninhighrisktype1longqtsyndromea22yearfollowup |